Health Sciences Portfolio
Data updated: 2026-08-11
C000078112 — Health Sciences Portfolio. United States Large Cap Blend / Core Health Care Equity · $381.44M AUM. Holdings, fees, performance and SEC filings.
C000078112 Fund Overview
Health Sciences Portfolio is a US mutual fund managed by Pacific Select Fund, categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Pacific Select Fund
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $381.44M
- 1-year return: 22.5%
- SEC CIK: 0000813900
- SEC series ID: S000026043
- Share class ID: C000078112
C000078112 Investment Objective and Strategy
Health Sciences Portfolio describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Pacific Select Fund.
Investment objective
This Fund seeks long-term growth of capital.
Principal investment strategy
Under normal circumstances, this Fund invests at least 80% of its assets in equity securities of companies in the health sciences sector. These equity securities are primarily common stocks. The sub-adviser considers companies in the health sciences sector to include issuers within the Health Care sector, which is comprised of the health sciences industry and groups of health sciences-related industries, including health care equipment and supplies, health care providers and services, biotechnology, health care technology, life sciences tools & services and pharmaceuticals. Businesses within the health sciences and related industries include, but are not limited to, companies involved in the development, production, and distribution or delivery of medical and pharmaceutical products and services, companies engaged in biotechnology and medical research and development, companies that design, manufacture or distribute medical, dental and optical equipment and supplies, including diagnostic equipment, and companies that may also provide diagnostic services or operate health facilities and hospitals, or provide related administrative, management and financial support.
The Fund normally will invest more than 25% of its assets in securities of companies in health sciences and related industries. The Fund may invest in small-, mid- and large-capitalization companies. The Fund may invest without limit in foreign denominated securities of companies located in foreign countries, including emerging market countries. The Fund may also invest in foreign currency forward commitments, which are purchased or sold to hedge against currency fluctuations. The sub-adviser considers a variety of factors when choosing investments for the Fund, including identifying companies and industries that appear to have the potential for above-average returns and promising growth and value prospects. The sub-adviser may sell a holding when it reaches a price target, there is deterioration in the companys fundamentals, a change in macroeconomic outlook, valuation issues, a need to rebalance the portfolio, or when other opportunities appear more attractive.
The Fund may lend its portfolio holdings to certain financial institutions.
C000078112 Holdings
Top 10 holdings of Health Sciences Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co | 12.42% |
| Johnson & Johnson | 7.77% |
| UnitedHealth Group Inc | 6.12% |
| Merck & Co Inc | 5.24% |
| AbbVie Inc | 5.05% |
| Gilead Sciences Inc | 3.67% |
| Amgen Inc | 3.37% |
| Thermo Fisher Scientific Inc | 2.96% |
| Vertex Pharmaceuticals Inc | 2.80% |
| Clear Street | 2.70% |
C000078112 Portfolio Allocation
Asset-class allocation of Health Sciences Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 96.4% |
| Cash & Equivalents | 6.1% |
C000078112 Performance
Total returns for C000078112 (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 4.3% |
| 1 year | 22.5% |
| 3 years (annualised) | 8.7% |
| 5 years (annualised) | 5.1% |
C000078112 Risk Information
Risk metrics for C000078112, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 15.1%
C000078112 Costs and Fees
C000078112 costs about $115 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.15%
- Gross expense ratio: 1.15%
- Portfolio turnover: 54%
- Brokerage commissions: 2.06 bps of average net assets (SEC N-CEN)
C000078112 Cashflows
Over the 12 months to 2026-06, Health Sciences Portfolio had net outflows of $49.01M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | −$1.24M |
| 2026-05 | −$2.85M |
| 2026-04 | −$4.02M |
| 2026-03 | −$3.86M |
| 2026-02 | −$7.02M |
| 2026-01 | −$8.67M |
C000078112 Debt Constituents
No individual debt constituents are reported in Health Sciences Portfolio's latest SEC N-PORT filing.
C000078112 Prospectus and SEC Filings
Official Health Sciences Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-29
- Prospectus (485BPOS) — filed 2025-04-29
- Prospectus (485BPOS) — filed 2024-04-26
- Portfolio holdings (N-PORT) — filed 2026-08-11
- Portfolio holdings (N-PORT) — filed 2026-05-27
- Portfolio holdings (N-PORT) — filed 2026-02-18
- Annual census (N-CEN) — filed 2026-03-12
- Annual census (N-CEN) — filed 2025-03-10
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.